Stock listing

LS Exchange:A3ETCE Precipio, Inc. Aktie

German listing (LS Exchange) of Precipio, Inc. · home listing NASDAQ:PRPO

Follow Precipio, Inc. into a list and get an email when it puts out news.

Home listing price · NASDAQ:PRPO

$17.35 USD -1.41 (-7.5%)

Close on Nov 20, 2026 · This listing has no price on 6ix; the price shown is the home listing's, NASDAQ:PRPO

Past year -32.3% · daily closes, Nov 20, 2025 – Nov 20, 2026, adjusted for splits
Day range
$17.30 – $19.11 USDNov 20, 2026
Volume
35,645 sharesNov 20, 2026
Market cap
$31.11M USDAt the close on Nov 20, 2026 · price × 1.79M shares outstanding
52-week range
$17.30 – $33.63 USDLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
Traded on an average day
$2.20M USDMedian day 43,500 shares · last 3 months, Aug 20, 2026 – Nov 20, 2026
Precipio, Inc. logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
NASDAQ:PRPO · Home$17.35 USD-1.41 (-7.5%)35,645$19.00$19.11$17.30$18.76Close on Nov 20, 2026

Daily closes

Last 3 months, Aug 20, 2026 – Nov 20, 2026 · NASDAQ:PRPO · USD, adjusted for splits

DayCloseChange%OpenHighLowVolume
$17.35-1.41-7.5%$19.00$19.11$17.3035,645
$18.76-0.41-2.1%$19.49$20.20$18.4636,728
$19.17-0.79-4.0%$20.19$21.19$18.4546,092
$19.96-2.17-9.8%$21.40$21.72$19.9629,080
$22.13-1.12-4.8%$21.99$22.68$21.8214,708
$23.25-1.55-6.3%$24.32$24.80$22.1722,938
$24.80+1.15+4.9%$23.20$25.03$22.7628,890
$23.65+1.45+6.5%$21.79$23.90$21.7917,724
$22.20+3.58+19.2%$19.00$22.92$19.0047,642
$18.62+0.03+0.2%$18.99$19.80$18.5013,871
$18.59-0.98-5.0%$18.71$20.24$18.4817,116
$19.57+0.95+5.1%$19.10$19.95$19.108,120
$18.62+0.83+4.7%$18.35$19.26$18.0017,968
$17.79-0.31-1.7%$18.48$18.70$17.7912,361
$18.10-1.25-6.5%$19.83$19.83$17.9925,900
$19.35+0.67+3.6%$19.00$19.99$19.0010,964
$18.68-0.23-1.2%$19.10$19.58$18.6825,160
$18.91-0.44-2.3%$19.57$19.83$18.9119,721
$19.35-0.66-3.3%$19.77$19.84$19.1032,988
$20.01-0.60-2.9%$20.57$20.65$19.9511,200
$20.61-0.64-3.0%$21.20$21.20$20.4727,600
$21.25-0.47-2.2%$21.79$22.45$21.03120,300
$21.72-0.17-0.8%$21.80$22.52$21.7226,600
$21.89+0.515+2.4%$21.45$22.28$21.4523,700
$21.38-1.165-5.2%$22.29$22.50$21.3895,100
$22.54+0.29+1.3%$22.24$22.81$22.0045,200
$22.25-0.34-1.5%$22.40$23.17$22.1542,500
$22.590.000.0%$22.57$23.01$21.9430,000
$22.59-0.53-2.3%$22.90$23.03$22.2012,000
$23.12-0.07-0.3%$23.14$23.82$22.9622,200
$23.19-0.33-1.4%$23.23$23.72$22.55118,000
$23.52+0.07+0.3%$22.95$24.03$22.9466,400
$23.45-0.55-2.3%$24.00$24.27$23.3018,200
$24.00+0.87+3.8%$23.11$24.12$22.9043,500
$23.13+0.40+1.8%$22.96$23.95$22.8822,700
$22.73-0.95-4.0%$23.79$23.83$22.4513,900
$23.68+0.10+0.4%$23.72$24.23$23.6374,200
$23.58-0.53-2.2%$23.71$23.75$22.9063,100
$24.11+0.46+1.9%$23.47$24.36$23.2672,400
$23.65-0.82-3.4%$24.33$24.62$23.4552,300
$24.47+0.63+2.6%$23.87$24.72$23.2358,200
$23.84-2.425-9.2%$26.22$26.31$23.5839,700
$26.27-0.525-2.0%$26.39$27.04$26.1180,500
$26.79+0.33+1.2%$26.50$26.80$26.00138,400
$26.46+0.02+0.1%$26.38$26.48$25.74192,300
$26.44-0.22-0.8%$26.98$26.98$26.09406,700
$26.66-0.50-1.8%$27.18$27.19$25.7239,100
$27.16-0.07-0.3%$27.23$27.71$26.53111,000
$27.23-0.09-0.3%$27.20$27.72$26.9062,600
$27.32+0.41+1.5%$27.03$28.00$26.2589,100
$26.91+1.31+5.1%$25.21$27.41$25.21236,300
$25.60-1.65-6.1%$27.10$27.10$25.50132,800
$27.25-0.15-0.5%$26.87$27.80$25.63304,100
$27.40+1.28+4.9%$26.11$27.90$24.48114,500
$26.12-1.38-5.0%$27.67$27.96$25.91423,800
$27.50-0.265-1.0%$27.93$28.16$26.77237,100
$27.77+0.075+0.3%$27.41$28.80$27.06211,200
$27.69-1.16-4.0%$28.85$29.91$27.2794,500
$28.85-0.44-1.5%$29.38$30.55$28.60205,200
$29.29-1.115-3.7%$30.30$30.39$28.8536,700
$30.41-0.445-1.4%$30.43$32.57$29.5791,000
$30.85-0.27-0.9%$30.96$31.82$30.07258,273
$31.12+0.67+2.2%$30.45$31.41$29.5429,686
$30.45+1.02+3.5%$29.48$30.45$27.0069,645
$29.43+1.58+5.7%$27.76$29.60$27.10366,640

Splits

2 splits since 2019 · NASDAQ:PRPO · every price before a split is adjusted for it

DayRatioWhat
1-for-20Consolidation
1-for-15Consolidation
Ticker
LS Exchange:A3ETCE
Asset type
Stock
Sector
Health care
Industry
Diagnostics & research services
Exchange
LS Exchange
Currency
EUR

What changed lately

Latest news

All Precipio, Inc. news

Precipio, Inc. on 6ix

Sector
Health care
Industry
Diagnostics & research services
News releases
14 in the last 12 months · 118 in all · newest Nov 10, 2026 · oldest 2019
Calls
9 calls with a replay · 9 with a transcript · latest Aug 17, 2026
Decks
5 decks · latest June 2026

Where Precipio, Inc. is listed

ListingExchangeCountryCurrency
NASDAQ:PRPO · Home listingNASDAQUnited StatesUSD
gettex:TGKgettexGermanyEUR
BOATS:PRPOBOATSUnited StatesUSD
LS Exchange:A3ETCE · This pageLS ExchangeGermanyEUR
Munich:TGKMunichGermanyEUR

Valuation

EV/sales 1.0× against a median of 1.9×: 3rd lowest of 10 Diagnostics & research services companies shown. Statements: 4 quarters to Sep 30, 2026 · price Nov 20, 2026

Enterprise value
$27.88M USD
P/E
Loss
EV/sales
1.0×
EV/EBITDA
119×
Price/book
2.1×
Gross margin
44.6%
Operating margin
−5.3%
Net margin
−4.1%
Debt to equity
0.0×
Beta vs S&P 500
1.00

Diagnostics & research services: the 10 companies nearest in size, of 302 on 6ix with figures. Size in US dollars.

CompanyMkt capEVP/EEV/SalesEV/EBITDAP/BNet mgnDebt/EqBeta
Precipio, Inc. · NASDAQ:PRPOUS$31.11MUS$27.88Mn/a1.0×119×2.1×−4.1%0.0×1.00
Trajan Group Holdings Ltd · ASX:TRJUS$34.98MUS$65.05Mn/a0.6×7.6×0.5×−0.4%0.6×n/a
Novacyt SAS · EURONEXT:ALNOVUS$33.87MUS$35.59Mn/a0.8×n/a1.4×−102.4%0.6×n/a
Rapid Micro Biosystems, Inc. · NASDAQ:RPIDUS$33.56MUS$46.06Mn/a1.3×n/a3.8×−138.2%2.2×1.41
Abnova Taiwan Corp. · TWSE:4133US$32.15MUS$20.35M23.6×1.9×13.4×0.8×13.0%0.0×n/a
Aligned Genetics, Inc. · KRX:238120US$31.02MUS$28.31M9.0×2.4×11.8×1.1×28.7%0.3×n/a
ENCell Co., Ltd. · KRX:456070US$30.74MUS$14.66Mn/a4.7×n/a1.5×−471.2%0.3×n/a
LabTurbo Biotech Corporation · TPEX:7725US$29.75MUS$4.98Mn/an/an/a0.8×n/a0.0×n/a
BioMark Diagnostics, Inc. · CSE:BUXUS$29.70MUS$29.15Mn/a1,504×n/a74.6×n/a0.0×-0.11
Bio Preventive Medicine Corp. · TPEX:6810US$29.41MUS$26.21Mn/a329×n/a3.7×n/a0.4×n/a
Abingdon Health PLC · LSE:ABDXUS$28.13MUS$26.13Mn/a1.8×n/a3.5×−19.4%0.2×n/a
Median of the othersUS$30.88MUS$27.26M16.3×1.9×11.8×1.4×−19.4%0.3×0.65

Team and board

Officers

OfficerRole
Ilan DanieliCEO
Matthew GageCFO
A. Zaki SabetCOO
Miri Chiko-RadomskiChief Legal Counsel and People Officer
Ayman MohamedCTO

Board

DirectorRole
Richard SandbergChairman of the Board
Christina ValauriDirector
David S. CohenDirector
Ilan DanieliCEO
Jeffrey CossmanDirector
Kathy LaPorteDirector
Ron A. AndrewsDirector

Events

Calls

CallWhenStatus
Precipio (NASDAQ:PRPO) Q2 2026 Earnings CallMon, Aug 17, 2026 · 5:00 PM ETReplay
Precipio (NASDAQ:PRPO) Q1 2026 Earnings CallMon, May 18, 2026 · 5:00 PM ETReplay
Precipio (NASDAQ:PRPO) Q4 2025 Earnings CallThu, Apr 02, 2026 · 5:00 PM ETReplay
Precipio (NASDAQ:PRPO) Q3 2025 Earnings CallMon, Nov 17, 2025 · 5:00 PM ETReplay
Precipio (NASDAQ:PRPO) Q2 2025 Earnings CallThu, May 15, 2025 · 5:00 PM ETReplay
Precipio (NASDAQ:PRPO) Q4 2022 Earnings CallMon, Apr 03, 2023 · 5:00 PM ETReplay
Precipio (NASDAQ:PRPO) Q3 2022 Earnings CallMon, Nov 14, 2022 · 5:00 PM ETReplay
Precipio (NASDAQ:PRPO) Q2 2022 Earnings CallMon, Aug 15, 2022 · 5:00 PM ETReplay
Precipio (NASDAQ:PRPO) Q4 2021 Earnings CallMon, Apr 04, 2022 · 5:00 PM ETReplay

Results days

QuarterResultsShare move
Q3 2026Nov 10, 2026 · After close+4.9%
Q2 2026Aug 14, 2026+3.0%
Q1 2026May 19, 2026−3.5%
Q3 2025Nov 14, 2025+7.7%
Q2 2025Aug 13, 2025+3.7%
Q1 2025May 12, 2025 · After close+11.4%
Q4 2024Mar 31, 2025 · After close−9.9%
Q3 2024Nov 11, 2024 · After close+2.3%
Q2 2024Aug 13, 2024 · After close−1.6%
Q1 2024May 14, 2024 · After close−3.9%
All 20 quarters
QuarterResultsShare move
Q3 2023Nov 13, 2023 · After close−1.4%
Q2 2023Aug 11, 2023 · After close−0.9%
Q1 2023May 12, 2023 · After close+0.2%
Q4 2022Mar 30, 2023 · After close+2.9%
Q3 2022Nov 10, 2022 · After close+4.9%
Q2 2022Aug 11, 2022 · After close+1.6%
Q1 2022May 11, 2022 · After close+1.0%
Q4 2021Mar 30, 2022 · After close+1.5%
Quarter to Sep 30, 2021Nov 12, 2021 · After close−2.2%
Quarter to Jun 30, 2021Aug 12, 2021 · After close−3.2%

Open Events

Decks

DeckKindSlidesDate
Investor Presentation (June 2026)Investor deck14 slidesJune 2026
Investor Presentation (August 2025)Investor deck12 slidesAugust 2025
Investor Presentation (June 2022)Investor deck12 slidesJun 13, 2022
Investor Presentation (2018)Investor deck17 slides2018
IPO Roadshow (August 2017)IPO roadshow23 slidesAug 2, 2017

Open Decks

Financings

RaiseDate
Warrant exercise of warrants
Terms changed: US$1.2M
Buyers: Largest warrant holder (100,000 warrants to be exercised with cash)
Jul 11, 2025

Open Financings · Read by 6ix AI from the company's releases

Financials

Annual, in USD

Income statement

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue24.0M18.5M15.2M9.41M8.85M6.09M3.13M2.86M1.72M1.72M
Cost of revenue13.3M11.0M9.18M6.90M6.46M4.94M2.91M2.64M1.43M970.0K
Gross profit10.7M7.56M6.02M2.51M2.39M1.15M219.0K225.0K292.0K753.0K
Research and development1.60M1.30M1.70M1.70M1.30M1.20M1.20M1.10M500.0K0
Selling, general and administrative11.7M13.5M15.2M11.9M10.3M9.62M9.45M6.49M2.46M
Operating income-1.20M-4.22M-7.62M-12.8M-9.61M-9.15M-11.0M-13.9M-15.5M-1.71M
Depreciation and amortization1.25M1.20M1.23M1.22M1.13M1.09M1.12M1.26M743.0K112.0K
EBITDA43.0K-3.02M-6.39M-11.6M-8.48M-8.05M-9.88M-12.6M-14.8M-1.60M
Interest expense73.0K74.0K18.0K12.0K20.0K470.0K473.0K1.60M2.32M518.0K
Income before tax-363.0K-4.29M-5.85M-12.2M-8.52M-10.6M-13.3M-16.0M-20.7M-2.23M
Income tax000000-70.0K-279.0K349.0K0
Net income-363.0K-4.29M-5.85M-12.2M-8.53M-14.0M-13.2M-15.7M-20.7M-2.23M
Earnings per share, basic-0.23-2.93-4.51-10.73-0.40-0.85-2.33-13.82-7.16-9.44
Earnings per share, diluted-0.23-2.93-4.51-10.73-0.40-0.85-2.33-13.82-7.16-9.44

Balance sheet

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash and equivalents2.65M1.39M1.50M3.44M11.7M2.66M848.0K381.0K421.0K51.0K
Short-term investments00
Receivables1.98M799.0K1.30M1.04M697.0K874.0K574.0K690.0K730.0K388.0K
Inventory935.0K724.0K384.0K708.0K564.0K350.0K184.0K197.0K161.0K100.0K
Current assets6.04M3.45M3.68M5.71M13.5M4.20M1.88M1.79M1.74M552.0K
Property, plant and equipment729.0K719.0K739.0K877.0K836.0K277.0K431.0K496.0K353.0K280.0K
Goodwill04.68M0
Total assets21.3M17.0M18.1M21.5M30.4M20.7M19.5M21.6M27.3M842.0K
Accounts payable1.13M618.0K622.0K2.04M1.86M1.69M1.94M5.17M5.10M1.08M
Current liabilities3.75M4.27M3.14M4.36M4.21M4.66M4.33M13.8M10.0M3.01M
Long-term debt47.0K77.0K106.0K134.0K160.0K362.0K198.0K253.0K2.83M4.13M
Total debt83.0K383.0K353.0K404.0K186.0K1.03M543.0K516.0K3.42M4.52M
Total liabilities6.76M4.90M3.67M5.14M5.83M6.55M6.31M15.5M14.2M7.30M
Shareholders' equity14.6M12.1M14.4M16.3M24.6M14.1M13.2M6.12M13.0M-6.46M
Shares outstanding1.78M1.49M1.42M1.14M22.7M17.6M7.90M2.30M10.2M449.2K

Cash flow

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations685.0K439.0K-3.56M-7.72M-6.58M-7.43M-9.14M-6.75M-6.69M-959.0K
Capital spending-326.0K-223.0K-126.0K-277.0K-682.0K-151.0K-55.0K-97.0K-143.0K-19.0K
Free cash flow359.0K216.0K-3.69M-8.00M-7.26M-7.58M-9.20M-6.85M-6.83M-978.0K
Cash from investing-326.0K-223.0K-126.0K-277.0K-682.0K-96.0K-55.0K-97.0K-42.0K1.01M
Cash from financing903.0K-329.0K1.74M-225.0K16.3M9.34M9.66M6.81M7.10M775.0K
Dividends paid-3.73M00
Share buybacks8.93M-1.00K3.28M7.81M2.26M
Change in cash1.26M-113.0K-1.94M-8.22M9.01M1.81M467.0K-40.0K370.0K-184.0K

Open Financials

Filings

FilingDateTypeFiled with
10-Q · Quarterly reportNov 10, 2026Quarterly reportSEC
8-K · Current reportNov 10, 2026ResultsSEC
8-K · Current reportOct 29, 2026Current reportSEC
4 · Change in ownershipOct 19, 2026Insider tradeSEC
4 · Change in ownershipOct 19, 2026Insider tradeSEC
8-K · Current reportAug 14, 2026ResultsSEC
10-Q · Quarterly reportAug 14, 2026Quarterly reportSEC
8-K · Current reportJul 31, 2026Current reportSEC
4 · Change in ownershipJul 16, 2026Insider tradeSEC
4 · Change in ownershipJul 16, 2026Insider tradeSEC
Show 200 filings
FilingDateTypeFiled with
4 · Change in ownershipJul 16, 2026Insider tradeSEC
8-K · Current reportJun 15, 2026Meeting outcomeSEC
4 · Change in ownershipMay 26, 2026Insider tradeSEC
4 · Change in ownershipMay 21, 2026Insider tradeSEC
144 · Notice of proposed saleMay 19, 2026Other filingsSEC
10-Q · Quarterly reportMay 14, 2026Quarterly reportSEC
8-K · Current reportMay 6, 2026Current reportSEC
ARS · Annual report to shareholdersApr 28, 2026Annual reportSEC
DEFA14A · Additional proxy materialApr 28, 2026Meeting noticeSEC
DEF 14A · Proxy statementApr 28, 2026Meeting noticeSEC
4 · Change in ownershipApr 17, 2026Insider tradeSEC
4 · Change in ownershipApr 17, 2026Insider tradeSEC
4 · Change in ownershipApr 17, 2026Insider tradeSEC
4 · Change in ownershipApr 10, 2026Insider tradeSEC
10-K · Annual reportMar 30, 2026Annual reportSEC
8-K · Current reportFeb 27, 2026ResultsSEC
SCHEDULE 13G/A · Big-stake notice, amendedFeb 10, 2026Big-stake noticeSEC
S-8 · Registration statement for employee plansJan 26, 2026Offer documentSEC
4/A · Change in ownership, amendedJan 20, 2026Insider tradeSEC
4/A · Change in ownership, amendedJan 20, 2026Insider tradeSEC
4/A · Change in ownership, amendedJan 20, 2026Insider tradeSEC
4/A · Change in ownership, amendedJan 20, 2026Insider tradeSEC
4/A · Change in ownership, amendedJan 20, 2026Insider tradeSEC
4/A · Change in ownership, amendedJan 20, 2026Insider tradeSEC
4 · Change in ownershipJan 20, 2026Insider tradeSEC
4 · Change in ownershipJan 20, 2026Insider tradeSEC
4 · Change in ownershipJan 20, 2026Insider tradeSEC
4 · Change in ownershipJan 20, 2026Insider tradeSEC
4 · Change in ownershipJan 6, 2026Insider tradeSEC
4 · Change in ownershipJan 6, 2026Insider tradeSEC
4 · Change in ownershipJan 6, 2026Insider tradeSEC
4 · Change in ownershipJan 6, 2026Insider tradeSEC
4 · Change in ownershipJan 6, 2026Insider tradeSEC
4 · Change in ownershipJan 6, 2026Insider tradeSEC
4 · Change in ownershipJan 6, 2026Insider tradeSEC
4 · Change in ownershipJan 6, 2026Insider tradeSEC
4 · Change in ownershipJan 6, 2026Insider tradeSEC
8-K · Current reportDec 29, 2025Management or board changeSEC
4 · Change in ownershipNov 20, 2025Insider tradeSEC
4 · Change in ownershipNov 20, 2025Insider tradeSEC
10-Q · Quarterly reportNov 14, 2025Quarterly reportSEC
8-K · Current reportNov 6, 2025Current reportSEC
SCHEDULE 13G/A · Big-stake notice, amendedOct 21, 2025Big-stake noticeSEC
4 · Change in ownershipOct 16, 2025Insider tradeSEC
4 · Change in ownershipOct 16, 2025Insider tradeSEC
4 · Change in ownershipOct 16, 2025Insider tradeSEC
4 · Change in ownershipOct 16, 2025Insider tradeSEC
SCHEDULE 13G · Big-stake noticeSep 22, 2025Big-stake noticeSEC
4 · Change in ownershipSep 10, 2025Insider tradeSEC
144 · Notice of proposed saleSep 9, 2025Other filingsSEC
8-K · Current reportSep 3, 2025Current reportSEC
8-K · Current reportAug 18, 2025Current reportSEC
10-Q · Quarterly reportAug 13, 2025Quarterly reportSEC
8-K · Current reportJul 31, 2025Current reportSEC
4/A · Change in ownership, amendedJul 18, 2025Insider tradeSEC
4 · Change in ownershipJul 18, 2025Insider tradeSEC
4 · Change in ownershipJul 18, 2025Insider tradeSEC
4 · Change in ownershipJul 18, 2025Insider tradeSEC
8-K · Current reportJun 17, 2025Meeting outcomeSEC
DEFA14A · Additional proxy materialJun 16, 2025Meeting noticeSEC
4 · Change in ownershipMay 30, 2025Insider tradeSEC
4 · Change in ownershipMay 28, 2025Insider tradeSEC
4 · Change in ownershipMay 27, 2025Insider tradeSEC
4 · Change in ownershipMay 22, 2025Insider tradeSEC
4/A · Change in ownership, amendedMay 22, 2025Insider tradeSEC
4 · Change in ownershipMay 21, 2025Insider tradeSEC
8-K · Current reportMay 15, 2025ResultsSEC
10-Q · Quarterly reportMay 14, 2025Quarterly reportSEC
8-K · Current reportMay 6, 2025Current reportSEC
ARS · Annual report to shareholdersApr 30, 2025Annual reportSEC
DEFA14A · Additional proxy materialApr 30, 2025Meeting noticeSEC
DEF 14A · Proxy statementApr 30, 2025Meeting noticeSEC
4 · Change in ownershipApr 17, 2025Insider tradeSEC
4 · Change in ownershipApr 17, 2025Insider tradeSEC
4 · Change in ownershipApr 17, 2025Insider tradeSEC
4 · Change in ownershipApr 17, 2025Insider tradeSEC
8-K · Current reportApr 9, 2025Current reportSEC
4 · Change in ownershipApr 4, 2025Insider tradeSEC
10-K · Annual reportMar 27, 2025Annual reportSEC
8-K · Current reportMar 17, 2025Current reportSEC
8-K · Current reportJan 21, 2025Management or board changeSEC
4 · Change in ownershipJan 16, 2025Insider tradeSEC
4 · Change in ownershipJan 16, 2025Insider tradeSEC
4 · Change in ownershipJan 16, 2025Insider tradeSEC
4 · Change in ownershipJan 16, 2025Insider tradeSEC
4 · Change in ownershipJan 16, 2025Insider tradeSEC
4 · Change in ownershipJan 16, 2025Insider tradeSEC
4 · Change in ownershipJan 16, 2025Insider tradeSEC
4 · Change in ownershipJan 16, 2025Insider tradeSEC
4 · Change in ownershipJan 16, 2025Insider tradeSEC
4 · Change in ownershipJan 16, 2025Insider tradeSEC
4 · Change in ownershipJan 16, 2025Insider tradeSEC
4 · Change in ownershipJan 16, 2025Insider tradeSEC
8-K · Current reportJan 16, 2025Current reportSEC
S-8 · Registration statement for employee plansJan 16, 2025Offer documentSEC
4/A · Change in ownership, amendedDec 23, 2024Insider tradeSEC
4/A · Change in ownership, amendedDec 23, 2024Insider tradeSEC
4 · Change in ownershipDec 13, 2024Insider tradeSEC
144 · Notice of proposed saleDec 11, 2024Other filingsSEC
4 · Change in ownershipNov 12, 2024Insider tradeSEC
144 · Notice of proposed saleNov 12, 2024Other filingsSEC
8-K · Current reportNov 6, 2024Current reportSEC
10-Q · Quarterly reportNov 6, 2024Quarterly reportSEC
4 · Change in ownershipOct 17, 2024Insider tradeSEC
4 · Change in ownershipOct 17, 2024Insider tradeSEC
4 · Change in ownershipOct 17, 2024Insider tradeSEC
4 · Change in ownershipOct 17, 2024Insider tradeSEC
4 · Change in ownershipOct 17, 2024Insider tradeSEC
4 · Change in ownershipSep 6, 2024Insider tradeSEC
4 · Change in ownershipSep 6, 2024Insider tradeSEC
4 · Change in ownershipSep 6, 2024Insider tradeSEC
4 · Change in ownershipSep 6, 2024Insider tradeSEC
4 · Change in ownershipSep 6, 2024Insider tradeSEC
4 · Change in ownershipSep 6, 2024Insider tradeSEC
4 · Change in ownershipSep 6, 2024Insider tradeSEC
8-K · Current reportSep 6, 2024Management or board changeSEC
8-K · Current reportAug 15, 2024Current reportSEC
10-Q · Quarterly reportAug 13, 2024Quarterly reportSEC
SC 13G · Big-stake noticeAug 2, 2024Big-stake noticeSEC
4 · Change in ownershipJul 16, 2024Insider tradeSEC
4 · Change in ownershipJul 16, 2024Insider tradeSEC
4 · Change in ownershipJul 16, 2024Insider tradeSEC
4 · Change in ownershipJul 16, 2024Insider tradeSEC
4 · Change in ownershipJun 25, 2024Insider tradeSEC
4 · Change in ownershipJun 25, 2024Insider tradeSEC
4 · Change in ownershipJun 25, 2024Insider tradeSEC
4 · Change in ownershipJun 25, 2024Insider tradeSEC
4 · Change in ownershipJun 25, 2024Insider tradeSEC
4 · Change in ownershipJun 25, 2024Insider tradeSEC
4 · Change in ownershipJun 25, 2024Insider tradeSEC
4 · Change in ownershipJun 25, 2024Insider tradeSEC
8-K · Current reportJun 25, 2024Meeting outcomeSEC
DEFA14A · Additional proxy materialJun 13, 2024Meeting noticeSEC
DEFA14A · Additional proxy materialJun 13, 2024Meeting noticeSEC
10-Q · Quarterly reportMay 14, 2024Quarterly reportSEC
8-K · Current reportMay 6, 2024Material contractSEC
8-K · Current reportMay 1, 2024Current reportSEC
ARS · Annual report to shareholdersApr 29, 2024Annual reportSEC
DEFA14A · Additional proxy materialApr 29, 2024Meeting noticeSEC
DEF 14A · Proxy statementApr 29, 2024Meeting noticeSEC
4 · Change in ownershipApr 17, 2024Insider tradeSEC
4 · Change in ownershipApr 17, 2024Insider tradeSEC
4 · Change in ownershipApr 17, 2024Insider tradeSEC
4 · Change in ownershipApr 17, 2024Insider tradeSEC
4 · Change in ownershipApr 17, 2024Insider tradeSEC
4 · Change in ownershipApr 17, 2024Insider tradeSEC
424B5 · ProspectusApr 8, 2024Offer documentSEC
S-8 · Registration statement for employee plansMar 29, 2024Offer documentSEC
10-K · Annual reportMar 29, 2024Annual reportSEC
8-K · Current reportMar 26, 2024Current reportSEC
424B5 · ProspectusJan 19, 2024Offer documentSEC
4 · Change in ownershipJan 4, 2024Insider tradeSEC
3 · Initial statement of ownershipJan 4, 2024Insider tradeSEC
8-K · Current reportJan 2, 2024Management or board changeSEC
8-K · Current reportDec 14, 2023Current reportSEC
8-K · Current reportNov 16, 2023Current reportSEC
10-Q · Quarterly reportNov 13, 2023Quarterly reportSEC
4 · Change in ownershipOct 31, 2023Insider tradeSEC
4 · Change in ownershipOct 26, 2023Insider tradeSEC
4 · Change in ownershipOct 26, 2023Insider tradeSEC
4 · Change in ownershipOct 26, 2023Insider tradeSEC
8-K · Current reportOct 6, 2023Current reportSEC
8-K · Current reportSep 21, 2023Current reportSEC
4 · Change in ownershipSep 14, 2023Insider tradeSEC
4 · Change in ownershipSep 14, 2023Insider tradeSEC
4 · Change in ownershipSep 14, 2023Insider tradeSEC
4 · Change in ownershipSep 14, 2023Insider tradeSEC
4 · Change in ownershipSep 14, 2023Insider tradeSEC
4 · Change in ownershipSep 14, 2023Insider tradeSEC
8-K · Current reportAug 14, 2023Current reportSEC
10-Q · Quarterly reportAug 11, 2023Quarterly reportSEC
EFFECT · Notice that a registration is effectiveJul 20, 2023Other filingsSEC
CORRESP · Letter to the SECJul 17, 2023Other filingsSEC
UPLOAD · Letter from the SECJul 14, 2023Other filingsSEC
S-1 · Registration statementJul 7, 2023Offer documentSEC
8-K · Current reportJun 15, 2023Meeting outcomeSEC
8-K · Current reportJun 12, 2023Material contractSEC
424B5 · ProspectusJun 9, 2023Offer documentSEC
8-K · Current reportMay 15, 2023Current reportSEC
10-Q · Quarterly reportMay 12, 2023Quarterly reportSEC
EFFECT · Notice that a registration is effectiveApr 28, 2023Other filingsSEC
8-K · Current reportApr 27, 2023Current reportSEC
CORRESP · Letter to the SECApr 25, 2023Other filingsSEC
S-3/A · Registration statement, amendedApr 25, 2023Offer documentSEC
DEFA14A · Additional proxy materialApr 25, 2023Meeting noticeSEC
DEF 14A · Proxy statementApr 25, 2023Meeting noticeSEC
UPLOAD · Letter from the SECApr 20, 2023Other filingsSEC
8-K · Current reportApr 14, 2023Material contractSEC
S-3 · Registration statementApr 14, 2023Offer documentSEC
ARS · Annual report to shareholdersApr 14, 2023Annual reportSEC

This page holds 200 of 1,000 filings. Open Filings

Open Filings · All of its filings on SEC EDGAR

Cap table

Built by 6ix from Precipio, Inc.’s releases · as of Nov 6, 2026

Common shares
1,792,935
Fully diluted
1,792,935

Fully diluted

LineSharesAs of
Common shares1,792,935Nov 6, 2026

Share count over time

CountShares
Nov 6, 20261,792,935

Open Cap table

Shareholders

Institutions

HolderSharesOf the companyValueChange vs Jun 30Filed
Two Sigma77,0404.3%US$1.82MNewNov 16, 2026
Vanguard67,9443.8%US$1.61M+12,389Nov 13, 2026
BlackRock34,4101.9%US$815K−245Nov 13, 2026
Jane Street32,4651.8%US$769KNewNov 12, 2026
Geode Capital17,1800.96%US$407K−1,511Nov 6, 2026
XTX Topco Ltd15,7100.88%US$372K+6,260Nov 16, 2026
Trexquant Investment LP11,8480.66%US$281KNewNov 16, 2026
UBS9,9290.55%US$235K+9,586Nov 10, 2026
Hrt Financial LP8,7790.49%US$207KNewNov 13, 2026
BNP Paribas2,4640.14%US$58,348NewNov 12, 2026
All 18 holders
HolderSharesOf the companyValueChange vs Jun 30Filed
Morgan Stanley4070.02%US$9,638+400Nov 13, 2026
RBC64<0.01%US$2,000+53Nov 16, 2026
Wells Fargo50<0.01%US$1,184No changeNov 16, 2026
Tower Research Capital LLC (TRC)28<0.01%US$663−4Nov 16, 2026
Caitong International Asset Management Co., Ltd4<0.01%US$95+3Oct 29, 2026
IFP Advisors, Inc3<0.01%US$71No changeOct 16, 2026
Allworth Financial LP3<0.01%US$72No changeNov 17, 2026
Fidelity2<0.01%US$52No changeNov 10, 2026

Funds

HolderSharesOf the companyValueChangeAs of
Vanguard Total Stock Market Index Fund28,3671.6%US$702K+19,096Jun 30, 2026
Vanguard Extended Market Index Fund17,6950.99%US$438K+1,483Jun 30, 2026
Fidelity Extended Market Index Fund8,0350.45%US$183K+486May 31, 2026
iShares Micro-Cap ETF5,3880.30%US$133KNewJun 30, 2026
Fidelity Total Market Index Fund3,1880.18%US$72,686+1,320May 31, 2026
Fidelity Nasdaq Composite Index Fund3,0970.17%US$70,612No changeMay 31, 2026
U.S. Micro Cap Portfolio2,6160.15%US$56,636NewJul 31, 2026
Fidelity Series Total Market Index Fund2,2720.13%US$51,802+315May 31, 2026
Dimensional U.S. Small Cap ETF1,2440.07%US$26,933+622Jul 31, 2026
Dimensional US Sustainability Core 1 ETF1,0080.06%US$21,823No changeJul 31, 2026
All 18 holders
HolderSharesOf the companyValueChangeAs of
U.S. Core Equity 1 Portfolio6140.03%US$13,293No changeJul 31, 2026
Dimensional U.S. Core Equity 2 ETF4790.03%US$10,370NewJul 31, 2026
U.S. Vector Equity Portfolio4560.03%US$9,872NewJul 31, 2026
U.S. Social Core Equity 2 Portfolio4100.02%US$8,877No changeJul 31, 2026
1290 VT Micro Cap Portfolio3550.02%US$8,790NewJun 30, 2026
Dimensional US Core Equity 1 ETF114<0.01%US$2,468No changeJul 31, 2026
U.S. Core Equity 2 Portfolio100<0.01%US$2,165No changeJul 31, 2026
Vanguard Balanced Index Fund86<0.01%US$2,129NewJun 30, 2026

Insider trades

InsiderTradeSharesPriceValueDate
Sandberg Richard A
Director
Sale900USD 25.02US$22,518May 21, 2026
Sandberg Richard A
Director
Sale500USD 25.00US$12,500May 20, 2026
Sandberg Richard A
Director
Sale2,034USD 24.89US$50,626May 20, 2026
Sandberg Richard A
Director
Sale600USD 24.42US$14,652May 19, 2026
Sabet Ahmed Zaki
Officer: Chief Operating Officer
Buy19USD 27.93US$531Apr 1, 2026

Open Shareholders

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Kathleen LaPorte
Other companies: Q32 Bio Inc. (Director · Since at least Mar 25, 2024); 89bio Inc (Director · Since at least Nov 1, 2021); CERo Therapeutics Holdings, Inc. (Director · Since at least Oct 5, 2021); Bolt Biotherapeutics, Inc. (Director · Since at least Feb 4, 2021); Paratek Pharmaceuticals Inc (Director · Jan 30, 2009 – Jan 24, 2012 · Past); Affymax Inc (Director · Dec 14, 2006 – Dec 14, 2012 · Past); eHealth, Inc. (Director · Oct 12, 2006 – Oct 12, 2006 · Past); Ista Pharmaceuticals Inc (Director · Jun 22, 2006 – Apr 13, 2011 · Past); Adeza Biomedical Corp (Director · Jun 6, 2006 – Jun 6, 2006 · Past); Vnus Medical Technologies Inc (Director · May 25, 2006 – May 23, 2008 · Past)
Director · Since at least Aug 7, 2018
Douglas Carl Fisher
Other companies: CERo Therapeutics Holdings, Inc. (President · Oct 5, 2021 – Feb 14, 2024 · Past); Sera Prognostics, Inc. (Chief Business Officer · Jul 14, 2021 – Jan 10, 2022 · Past); Vyome Holdings, Inc. (Director · Oct 5, 2016 – Sep 16, 2020 · Past)
Director · Sep 26, 2017 – Oct 27, 2023 · Past
Mark P Colonnese
Other companies: Bio-Path Holdings, Inc. (Director · Jul 13, 2017 – Mar 28, 2019 · Past); Vaxart, Inc. (Chief Financial Officer · Nov 2, 2015 – Apr 3, 2017 · Past); Atherogenics Inc (VP Commercial Operations & CFO · Feb 21, 2006 – Dec 31, 2008 · Past)
Chief Financial Officer · Sep 12, 2012 – Feb 18, 2014 · Past
Richard Sandberg
Other companies: Oxford Immunotec Global PLC (Director · Nov 21, 2013 – Mar 8, 2021 · Past); Ethan Allen Interiors Inc. (Director · Jul 25, 2006 – Jul 24, 2009 · Past); North American Scientific Inc (Director · May 3, 2006 – Apr 29, 2008 · Past)
Chairman of the Board · Since at least Dec 3, 2019
Ronald Andrews
Other companies: Plus Therapeutics, Inc. (Director · Since at least Mar 20, 2026); Insight Molecular Diagnostics Inc. (Former CEO, Director · Jul 1, 2019 – Dec 1, 2022 · Past); Oxford Immunotec Global PLC (Director · Jun 18, 2019 – Mar 8, 2021 · Past)
Director · Since at least Mar 1, 2021
Samuel Riccitelli
Other companies: OrthoPediatrics Corp. (Director · Since at least Dec 14, 2017); Viridian Therapeutics, Inc. (President & CEO, Director · Jun 17, 2014 – Oct 31, 2016 · Past); Genoptix Inc (Ex VP and COO · Oct 29, 2007 – Mar 7, 2011 · Past)
Director · Jun 29, 2017 – Mar 18, 2019 · Past
Antonius Schuh
Other companies: Cardiff Oncology, Inc. (CEO, Director · Jan 23, 2012 – Jan 4, 2016 · Past); Sorrento Therapeutics, Inc. (Chairman and CEO, Director · Feb 16, 2010 – Feb 16, 2010 · Past)
Director · May 20, 2009 – Feb 18, 2014 · Past
Christina Valauri
Other companies: Valion Bio, Inc. (Director · Since at least Jul 1, 2024)
Director · Since at least Jan 2, 2024
Ilan Danieli
Other companies: Osiris Corporation (Chief Operating Officer · Apr 1, 2008 – Apr 1, 2008 · Past)
CEO · Since at least Jun 29, 2017
Michael A Luther
Other companies: Albany Molecular Research Inc (Senior VP, Discovery Services · Oct 28, 2013 – Feb 4, 2015 · Past)
Director · Mar 13, 2014 – Feb 16, 2018 · Past
All 38 people
PersonSeat
Rodney S Markin
Other companies: Cardiff Oncology, Inc. (Director · Since at least Feb 19, 2014)
Director · Mar 1, 2007 – Feb 18, 2014 · Past
Ahmed Zaki SabetChief Operating Officer · Since at least Dec 2, 2019
Ayman MohamedCTO · Since at least Nov 5, 2026
A. Zaki SabetCOO · Since at least Jun 11, 2026
Brett L FrevertChief Financial Officer · Jun 30, 2010 – May 18, 2011 · Past
Carl IbergerChief Financial Officer · Jun 29, 2017 – Jan 11, 2022 · Past
Chad M RichardsChief Commercial Officer · Jun 15, 2012 – Jun 15, 2012 · Past
Craig James TuttlePresident and CEO, Director · Jul 12, 2006 – May 3, 2013 · Past
David P PauluzziDirector · Jan 2, 2008 – Mar 10, 2008 · Past
David S. CohenDirector · Since at least Nov 8, 2017
Debra A SchneiderVice President and CFO · Dec 4, 2006 – Dec 7, 2007 · Past
Doit Koppler IIDirector · Dec 29, 2010 – Dec 13, 2016 · Past
Eric P KaldjianChief Scientific Officer · May 21, 2008 – Dec 9, 2008 · Past
Frank R WitneyDirector · Apr 9, 2007 – May 21, 2008 · Past
Gregory T SlomaDirector · Sep 1, 2006 – Jun 7, 2010 · Past
Jeffrey CossmanDirector · Since at least Sep 26, 2017
Jeffrey L SklarDirector · Sep 1, 2006 – Jun 7, 2010 · Past
John D ThompsonDirector · May 14, 2014 – Apr 1, 2015 · Past
Kathy LaPorteDirector · Since at least Nov 4, 2026
Mark RimerDirector · Sep 8, 2017 – Jan 11, 2022 · Past
Matthew GageCFO · Since at least Mar 21, 2022
Michael B McNultyDirector · May 20, 2009 – Jun 7, 2010 · Past
Miri Chiko-RadomskiChief Legal Counsel and People Officer · Since at least Nov 5, 2026
Mya ThomaeDirector · Jun 8, 2015 – Dec 13, 2016 · Past
Paul KinnonCEO, President and Interim CFO, Director · Sep 30, 2013 – Apr 1, 2015 · Past
Robert PatzigDirector · Dec 29, 2010 – Sep 26, 2017 · Past
Roland J SantoniDirector · Sep 1, 2006 – Nov 20, 2006 · Past
Ron A. AndrewsDirector · Since at least Nov 4, 2026

Open People

Log in to ask 6ix AI your own questions about Precipio, Inc.